Opzelura Ruxolitinib Cream for Vitiligo in pakistan

Best Price Opzelura Ruxolitinib Cream for Vitiligo in pakistan | Medicine Mart

Ruxolitinib is a topical Janus kinase (JAK) inhibitor found in Opzelura Ruxolitinib Cream. In patients who qualify, it is specially applied topically to cure nonsegmental vitiligo. Vitiligo is a disorder that causes regions of skin to become lighter or white due to the loss of normal pigmentation. Different parts of the body may be affected by nonsegmental vitiligo, and it may evolve over time. Inhibiting specific Janus kinase pathways involved in immunological signaling is how ruxolitinib functions. The potential of topical ruxolitinib to promote repigmentation in individuals with nonsegmental vitiligo has been investigated. Instead of being taken orally, Opzelura is intended to be applied topically to afflicted skin. Only the prescribing information and instructions supplied by a licensed healthcare provider should be followed when using the cream.

Ingredients

Active Ingredient

• Ruxolitinib Phosphate
• Equivalent to Ruxolitinib 1.5%

Product Form

• Topical cream

The exact inactive ingredients and current pack presentation should be verified against the actual product packaging supplied by the manufacturer.

Key Benefits / Uses

• Contains topical ruxolitinib
• Specifically formulated for topical skin application
• Used for nonsegmental vitiligo
• Helps support repigmentation of affected skin in eligible patients
• JAK inhibitor formulation
• Suitable for approved patient groups according to prescribing information
• Convenient topical cream format

Important: Opzelura should not be described as a permanent cure for vitiligo. Treatment response can vary between individuals.

How to Use

Use Opzelura exactly as prescribed by your healthcare professional.

Apply a thin layer to the affected areas according to the current prescribing instructions. Do not apply more frequently or use larger amounts than directed.

Avoid contact with the eyes, mouth and other sensitive areas unless specifically instructed by your healthcare professional.

Important Warnings

• Prescription medicine — use under appropriate medical supervision.
• For topical use only.
• Do not swallow.
• Avoid contact with the eyes and mucous membranes.
• Do not use on areas of skin not intended for treatment unless directed by your healthcare professional.
• Tell your doctor about other medicines you are taking.
• Discuss your medical history with your healthcare professional before treatment.
• Seek medical advice if you develop a serious or unusual reaction.
• Keep out of reach of children.
• Store according to the manufacturer’s instructions.
• Always follow the current official prescribing information.

Possible Side Effects

Like other medicines, Opzelura may cause side effects in some patients.

The prescribing information reports possible reactions including:

• Application-site acne
• Application-site redness
• Nasopharyngitis
• Headache
• Urinary tract infection
• Folliculitis
• Fever
• Allergic reactions

This is not a complete list of possible adverse reactions. Patients should read the official prescribing information and contact a healthcare professional if they experience concerning symptoms.

FAQs

1. What is Opzelura Ruxolitinib Cream?

Opzelura is a topical prescription medicine containing ruxolitinib, a JAK inhibitor used for certain inflammatory skin conditions, including nonsegmental vitiligo.

2. What strength is Opzelura used for vitiligo?

The Opzelura formulation for vitiligo contains ruxolitinib 1.5%.